Parasitology and Mycology Rapid Tests and Point of Care (POC) Pipeline Research Report 2023 - ResearchAndMarkets.com

2024-01-16

DUBLIN--(BUSINESS WIRE)--The "Parasitology and Mycology Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" report has been added to ResearchAndMarkets.com's offering.

'Parasitology and Mycology Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update'

Parasitology & Mycology Pipeline Report provides comprehensive information about the Parasitology & Mycology pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

This report provides extensive coverage of Parasitology & Mycology under development, offering comprehensive insights into pipeline products, major players, developmental activities, clinical trial data, and recent developments in the segment/industry.

The report reviews the details of major pipeline products, including product descriptions, licensing and collaboration details, and other developmental activities related to Parasitology & Mycology. It also lists all the pipeline projects involving major players engaged in the development of Parasitology & Mycology. Coverage of pipeline products is based on various stages of development, ranging from Early Development to Approved/Issued stages, allowing readers to understand the progress of these products in the pipeline.

Key clinical trial data related to ongoing trials specific to pipeline products in the Parasitology & Mycology segment is provided, offering valuable insights into the clinical development of these products.

Reasons to Buy

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Identify and understand important and diverse types of Parasitology & Mycology under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Parasitology & Mycology Overview

3 Products under Development

3.1 Parasitology & Mycology - Pipeline Products by Stage of Development

3.2 Parasitology & Mycology - Pipeline Products by Territory

3.3 Parasitology & Mycology - Pipeline Products by Regulatory Path

3.4 Parasitology & Mycology - Pipeline Products by Estimated Approval Date

4 Parasitology & Mycology - Pipeline Products under Development by Companies

4.1 Parasitology & Mycology Companies - Pipeline Products by Stage of Development

4.2 Parasitology & Mycology - Pipeline Products by Stage of Development

5 Parasitology & Mycology Companies and Product Overview

6 Parasitology & Mycology- Recent Developments

7 Appendix

A selection of companies mentioned in this report includes

Abacus Diagnostica Ltd

Access Bio Inc

Acobiom

Adaltis Srl

All India Institute of Medical Sciences

Antigen Discovery Inc

Axxin

BioSynesis Inc

Biotechnology Assets SA

Biotype Innovation GmbH

Cascade Biosystems Inc

Cepheid Inc

Cerebro Biosystems

Ceres Nanosciences Inc

Ellume Ltd

EUROIMMUN US LLC

FK-Biotecnologia SA

Foundation for Innovative New Diagnostics

Fungea AB

G Medical Health and Wellness

Genetag Technology, Inc

Gennova Biopharmaceuticals Ltd

Genome Diagnostics Pvt Ltd

George Mason University

Great Basin Scientific Inc.

HealthTell Inc

Immunetics Inc

InBios International Inc

Institute for Development Research

Johns Hopkins University

L2 Diagnostics LLC

London School of Hygiene & Tropical Medicine

Luminex Corp

Mahidol Oxford Tropical Medicine Research Unit

Masaryk University

Massachusetts Institute of Technology

McGill University

Meridian Bioscience Inc

Microbiologics Inc

MiraVista Diagnostics LLC

MND Diagnostic LTD

MycoDART Inc

Mylab Discovery Solutions Pvt Ltd

Nagasaki University

Nanosphere Inc (Inactive)

NextGen Invitro Diagnostics Pvt Ltd

Novacyt SA

Ohio State University

OpGen Inc

OPKO Health Inc

Oregon Health & Science University

Ortho Clinical Diagnostics Holdings Plc

Pai Life Sciences Inc

Paramedical Srl

Peruvian Cayetano Heredia University

Phagolum Ltd.

PixCell Medical Technologies Ltd

Praxis Pharmaceutical SAU

Proplex Technologies Llc

Qiagen NV

RealSeq Biosciences Inc

Roche Diagnostics International Ltd

Seegene Inc

Serimmune Inc

Siemens Healthcare Diagnostics Inc

T2 Biosystems Inc

Taizhou ZECEN Biotech Co Ltd

Techinvention Lifecare Pvt Ltd

The Walter and Eliza Hall Institute of Medical Research

Transfusion & Transplantation Technologies (Inactive)

University of California

University of Colorado

University of Edinburgh

University of Georgia

University of Grenoble Alpes

University of Oxford

University of Tennessee

Virginia Commonwealth University

Washington University in St Louis

Washington University School of Medicine

For more information about this report visit https://www.researchandmarkets.com/r/djd3pp

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.